Glucagon/insulin human(Abvance Therapeutics)

胰高血糖素/人胰岛素 (Abvance Therapeutics)

Report date: 2025/03/18 16:29:30

Base Information

Drug NameGlucagon/insulin human(Abvance Therapeutics)
Drug Alias NameABV-100
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGlucagon receptor agonistsInsulin receptor agonists
TargetsGlucagon receptorInsulin receptor
Therapy Area/IndicationsHypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes GlucagonInsulin human (inhalation powder)
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbvance Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAbvance Therapeutics
Inactive CompaniesN/A
Active IndicationsHypoglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A